Panacea Life Sciences 2020 revenue $9.0M, net loss $5.2M; auditor raises going concern

PANACEA LIFE SCIENCES HOLDINGS, INC.

Revenue $9.0M in 2020 vs $2.2M in 2019; net loss $5.2M vs $2.8M.
Cash dropped to $84K from $8.5M year-end 2019; total assets $31.4M, liabilities $24.7M.
Auditor raises going concern due to recurring losses; company needs additional capital.
Related party note payable $15.1M at Dec 2020; $1M additional financing received Nov 2021.
Marketable securities (XXII shares) valued at $2.85M; unrealized gain $1.43M in 2020.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.